Aeglea BioTherapeutics appoints Burrows as CFO, King-Jones as CLO
PremiumThe FlyAeglea BioTherapeutics appoints Burrows as CFO, King-Jones as CLO
1y ago
Aeglea BioTherapeutics reports Q2 EPS ($2.27) vs. (27c) last year
Premium
The Fly
Aeglea BioTherapeutics reports Q2 EPS ($2.27) vs. (27c) last year
1y ago
Aeglea BioTherapeutics files to sell 1.1M shares of common stock for holders
Premium
The Fly
Aeglea BioTherapeutics files to sell 1.1M shares of common stock for holders
1y ago
Aeglea downgraded at Wells Fargo after ADAs seen in pegtarviliase study
PremiumThe FlyAeglea downgraded at Wells Fargo after ADAs seen in pegtarviliase study
2y ago
Aeglea BioTherapeutics downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Aeglea BioTherapeutics downgraded to Equal Weight from Overweight at Wells Fargo
2y ago
Aeglea BioTherapeutics downgraded to Market Perform at LifeSci Capital
Premium
The Fly
Aeglea BioTherapeutics downgraded to Market Perform at LifeSci Capital
2y ago
Aeglea BioTherapeutics reports Q4 revenue $200K, consensus $60K
PremiumThe FlyAeglea BioTherapeutics reports Q4 revenue $200K, consensus $60K
2y ago
Aeglea BioTherapeutics announces 15% workforce reduction, COO departure
Premium
The Fly
Aeglea BioTherapeutics announces 15% workforce reduction, COO departure
2y ago
Aeglea: Jim Kastenmayer to retain position as general counsel
Premium
The Fly
Aeglea: Jim Kastenmayer to retain position as general counsel
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100